AB0356 TARGETING THE RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLAST VIA CYCLIN DEPENDENT KINASE INHIBITION (TRAFIC): A PHASE 1B STUDY TO DETERMINE THE MAXIMUM TOLERATED DOSE OF SELICICLIB FOR REPURPOSING IN RHEUMATOID ARTHRITIS (2020)
Attributed to:
MICA: Targeting the RA synovial fibroblast via cyclin dependent kinase inhibition - a phase IIa study
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2020-eular.2443
Publication URI: http://dx.doi.org/10.1136/annrheumdis-2020-eular.2443
Type: Journal Article/Review
Parent Publication: Annals of the Rheumatic Diseases
Issue: Suppl 1
ISSN: 0003-4967